Quantcast

Bluegrass Times

Friday, May 3, 2024

FDA conducted third highest number of inspections on Biologics companies in Kentucky during 2023

Webp r4rtnb3h764dx5zlstpe2fag0ycm

Hilary Marston, M.D., M.P.H. Chief Medical Officer (CMO) of the FDA | Official Website

Hilary Marston, M.D., M.P.H. Chief Medical Officer (CMO) of the FDA | Official Website

In 2023, nine Biologics companies received nine FDA inspections in Kentucky, according to the U.S. Food and Drug Administration (FDA).

This was the third highest number of inspections per type of company made by the FDA in Kentucky, equalling 7.9% of all inspections in 2023.

Of all the Kentucky companies involved in the Biologics sector, Louisville Reproductive Center received the most citations from the FDA in 2023.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

Top 10 FDA Inspections by Number of Actions Indicated in Kentucky During 2023
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Bioresearch Monitoring41--
Blood and Blood Products8----
Compliance: Devices71--
Drug Quality Assurance21--
Food Composition, Standards, Labeling and Econ--4--
Foodborne Biological Hazards41121
Monitoring of Marketed Animal Drugs, Feed, and Devices254--
Postmarket Assurance: Devices12--
Technical Assistance: Food and Cosmetics83--
Vaccines and Allergenic Products3----

MORE NEWS